Antibody News

Bcl-2 Antibodies And Apoptosis Research

Monday, December 14, 2009 - 10:00

Bcl-2 antibodies are used as markers for the Bcl-2 gene. Bcl-2 suppresses apoptosis (controlled cell death) by inhibiting caspase activity and controlling cell membrane permeability. It does this by forming mitochondrial pores on the outer membrane of the mitochondria. However, its exact mechanism of action is still not completely understood.

There are more than 25 Bcl-2 proteins, which are membrane bound and regulate apoptosis both positively and negatively. We at Novus Biologicals have a broad antibody database specific to the Bcl-2 gene, as well as anti-Bax antibodies. These two proteins are closely related, as Bax is a pro-apoptotic protein of the Bcl-2 family, forming channels in lipid membranes.

In planar lipid bilayer experiments, Bax formed ion-conducting channels which were both voltage and pH dependent. Further studies used Bax to trigger...

GTPase Regulators And Their Antibodies

Friday, December 11, 2009 - 10:00

Researchers routinely use GTP binding antibodies for the research of human disease. Thus it is worthwhile to provide a recap of the GTP binding process.

GTPases, a type of heterotrimeric G proteins, are essential to all metabolic functions. They act as molecular switches on the cell membrane, activating in response to various chemical signals. For example hormones, cytokines, physical stresses and cell-to-cell communications all activate downstream pathways. The interactions are complex, each requiring a different GTP protein. These function as molecular switches to activate or deactivate specific cellular responses.

G-proteins work by hydrolyzing GTP (guanosine triphosphate). They switch between active and inactive states, depending on whether they are GTP (guanosine triphosphate) or GDP (guanosine diphosphate) bound. In their active (GTP) state, they interact with effectors to initiate a downstream signal. In their GDP state...

Use Of FANC Antibodies To Study The Fanconi Anaemia Pathway In F And D1 cells

Wednesday, December 9, 2009 - 10:00

Fanconi anaemia (FA) is an autosomal-recessive disorder, characterized by skeletal abnormalities, progressive bone marrow failure and cellular hypersensitivity to DNA damaging agents such as Mitomycin C. FA also increases the likelihood of cancerous tumors and childhood leukemia.

Fanconi anaemia (FA) is a known complication of cancer therapy, and the use of FANC antibodies form a routine part of cancer research. Antibody suppliers, such as Novus Biologicals, supply anti-FANC antibodies which interact with FANC proteins in Western blot analysis and similar assays.

The FANCD2 protein is of particular importance, and is activated via the interaction of several other FANC proteins in a nuclear complex. This process (known as monoubiquitination) results in the formation of FANCD2/BRCA1 nuclear foci.

The FANCD2...

The Role Of Antibodies In Cobalt Chloride Induced Apoptosis In PC12 Cells

Monday, December 7, 2009 - 10:00

Various studies have been performed tracking the involvement of p38 mitogen-activated protein kinase (MAPK) and caspase-3 antibodies in cobalt chloride (CoCl2) induced apoptosis in PC12 cells.

Studies have proven the usefulness of CoCl2 treatment to induce apoptosis in PC12 rat tumor cells. Treating these cells with CoCl2 leads to programmed cell death (apoptosis). Such cells provide a simple and useful model for the study of hypoxia-related neuronal disorders, as hypoxia involves a lack of oxygen.

The mechanism of action is known to involve caspase cleavage. Antibody suppliers, such as Novus Biologicals, supply caspase and p38 antibody preparations, which are then used to study caspase cleavage in PC12 cells. p38 MAP Kinase (MAPK), also known as RK and CSBP, is known to be a pro-apoptotic factor, which when activated leads to the cleavage of caspase-3; thus, MAPK antibodies and...


Blog Topics